BioStem Technologies (BSEM) News Today $14.69 +0.16 (+1.11%) As of 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period BioStem Technologies, Inc. (OTCMKTS:BSEM) Sees Significant Growth in Short InterestBioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report) was the recipient of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 170,200 shares, an increase of 20.5% from the March 15th total of 141,300 shares. Based on an average trading volume of 85,600 shares, the short-interest ratio is presently 2.0 days. Currently, 1.0% of the shares of the stock are sold short.April 23 at 7:33 AM | marketbeat.comShort Interest in BioStem Technologies, Inc. (OTCMKTS:BSEM) Expands By 20.5%April 22 at 3:49 AM | americanbankingnews.comBioStem Technologies to Present at the Centri Capital ConferenceApril 21, 2025 | globenewswire.comBioStem Technologies (OTCMKTS:BSEM) Posts Quarterly Earnings Results, Beats Estimates By $0.31 EPSBioStem Technologies (OTCMKTS:BSEM - Get Free Report) announced its quarterly earnings results on Monday. The company reported $0.68 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.31.April 16, 2025 | marketbeat.comBioStem Technologies (OTCMKTS:BSEM) Announces Quarterly Earnings Results, Beats Estimates By $0.31 EPSBioStem Technologies (OTCMKTS:BSEM - Get Free Report) posted its quarterly earnings results on Monday. The company reported $0.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.31.April 16, 2025 | marketbeat.comBSEM Posts Record Revenue and ProfitApril 15, 2025 | msn.comBioStem Technologies, Inc. (BSEM) Q4 2024 Earnings Call TranscriptApril 14, 2025 | seekingalpha.comBioStem Technologies Reports Record Preliminary Fourth-Quarter Net Revenue of $102.9 Million and Preliminary Full-Year 2024 Revenue of $301.8 MillionApril 14, 2025 | globenewswire.comBioStem Technologies to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on April 14, 2025April 8, 2025 | globenewswire.comBioStem Technologies (BSEM) to Release Quarterly Earnings on MondayBioStem Technologies (OTCMKTS:BSEM) will be releasing earnings after the market closes on Monday, April 7, Financial Modeling Prep reports.April 6, 2025 | marketbeat.comBioStem Technologies Announces Extension to File 2024 Annual Report with OTCApril 1, 2025 | globenewswire.comBioStem Technologies, Inc. (OTCMKTS:BSEM) Sees Large Drop in Short InterestBioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 141,300 shares, a drop of 32.2% from the February 28th total of 208,400 shares. Approximately 0.8% of the shares of the company are sold short. Based on an average trading volume of 87,900 shares, the days-to-cover ratio is currently 1.6 days.March 31, 2025 | marketbeat.comBioStem Announces Notice of Allowance for Two U.S. Patent ApplicationsMarch 31, 2025 | globenewswire.comBioStem Technologies (BSEM) to Release Earnings on MondayBioStem Technologies (OTCMKTS:BSEM) will be releasing earnings after the market closes on Monday, April 7, Financial Modeling Prep reports.March 31, 2025 | marketbeat.comBioStem Technologies to Present at the 24th Annual Needham Virtual Healthcare ConferenceMarch 27, 2025 | globenewswire.comBioStem Technologies (OTCMKTS:BSEM) Shares Up 7.1% - What's Next?BioStem Technologies (OTCMKTS:BSEM) Trading Up 7.1% - Time to Buy?March 22, 2025 | marketbeat.comBioStem Technologies: Building On Advanced Wound Care NeedsMarch 17, 2025 | seekingalpha.comBioStem Technologies (OTCMKTS:BSEM) Stock Price Up 0.6% - Should You Buy?BioStem Technologies (OTCMKTS:BSEM) Shares Up 0.6% - Here's WhyMarch 1, 2025 | marketbeat.comBSEM Continues to ExcelFebruary 24, 2025 | msn.comBioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Trial Demonstrating the Therapeutic Benefits of BioREtain® Technology in Treating Venous Leg UlcersFebruary 24, 2025 | globenewswire.comBiostem Technologies IncFebruary 23, 2025 | investing.comShort Interest in BioStem Technologies, Inc. (OTCMKTS:BSEM) Increases By 38.8%BioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report) was the target of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 191,200 shares, an increase of 38.8% from the December 15th total of 137,800 shares. Based on an average daily trading volume, of 98,300 shares, the short-interest ratio is presently 1.9 days.January 15, 2025 | marketbeat.comBioStem Technologies Launches Clinical Trial to Demonstrate the Therapeutic Benefits of its BioREtain® Technology in Treating Diabetic Foot Ulcers Using Vendaje®January 8, 2025 | globenewswire.comBioStem Technologies CEO to Present at Biotech Showcase 2025January 2, 2025 | globenewswire.comBioStem Technologies, Inc. (OTCMKTS:BSEM) Short Interest UpdateBioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report) was the recipient of a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 137,800 shares, a growth of 17.1% from the November 30th total of 117,700 shares. Based on an average daily volume of 120,600 shares, the days-to-cover ratio is currently 1.1 days.December 29, 2024 | marketbeat.comKane Biotech Announces Change in US Distribution Partner for revyve™ Antimicrobial Wound GelNovember 27, 2024 | globenewswire.comBioStem Announces Notice of Allowance for U.S. Patent Application for Sterile Human Placental AllograftsNovember 25, 2024 | globenewswire.comBioStem Technologies, Inc.: BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare GlobalNovember 21, 2024 | finanznachrichten.deBioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare GlobalNovember 20, 2024 | globenewswire.comQ4 EPS Estimates for OTCMKTS:BSEM Raised by Zacks Small CapBioStem Technologies, Inc. (OTCMKTS:BSEM - Free Report) - Investment analysts at Zacks Small Cap upped their Q4 2024 EPS estimates for BioStem Technologies in a research note issued to investors on Friday, November 15th. Zacks Small Cap analyst B. Sorensen now expects that the company will post eNovember 18, 2024 | marketbeat.comBSEM: Medicare Issues Shouldn’t Impact BioStemNovember 15, 2024 | finance.yahoo.comLong-Term, BioStem Technologies Still A Promising Growth StockNovember 15, 2024 | seekingalpha.comBioStem Technologies, Inc. (OTCMKTS:BSEM) Sees Significant Increase in Short InterestBioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report) was the target of a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 115,100 shares, an increase of 22.3% from the October 15th total of 94,100 shares. Based on an average daily volume of 124,800 shares, the short-interest ratio is presently 0.9 days.November 15, 2024 | marketbeat.comBioStem Technologies, Inc. (BSEM) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | seekingalpha.comBSEM Continues to Exceed ExpectationsNovember 13, 2024 | msn.comBioStem Technologies Achieves Record Revenue Growth in Q3 2024November 13, 2024 | markets.businessinsider.comBioStem Technologies Initiates Nationwide Launch of Vendaje AC® with Venture Medical Following Established Reimbursement in All Medicare Administrative Contractor (MAC) RegionsOctober 29, 2024 | globenewswire.comBioStem Technologies to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024October 28, 2024 | globenewswire.comOTCMKTS:BSEM Q3 EPS Estimate Raised by Zacks Small CapBioStem Technologies, Inc. (OTCMKTS:BSEM - Free Report) - Analysts at Zacks Small Cap boosted their Q3 2024 earnings per share estimates for shares of BioStem Technologies in a research note issued on Thursday, October 17th. Zacks Small Cap analyst B. Sorensen now anticipates that the company wilOctober 18, 2024 | marketbeat.comBSEM Announces Expanding Market and Stellar Test ResultsOctober 17, 2024 | msn.comBioStem Technologies, Inc. (OTCMKTS:BSEM) Short Interest Up 41.1% in SeptemberBioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report) was the recipient of a large increase in short interest during the month of September. As of September 30th, there was short interest totalling 88,600 shares, an increase of 41.1% from the September 15th total of 62,800 shares. Based on an average daily trading volume, of 57,200 shares, the days-to-cover ratio is currently 1.5 days.October 13, 2024 | marketbeat.comBSEM Initiates Trial and Start Uplisting ProcessOctober 2, 2024 | msn.comBioStem Technologies Initiates BR-AC-DFU-101 Clinical Trial to Study BioREtain® in Diabetic Foot UlcersOctober 2, 2024 | globenewswire.comBioStem Technologies Inc.September 11, 2024 | wsj.comBioStem Technologies, Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ETAugust 29, 2024 | globenewswire.comBioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Study Evaluating the Value of Vendaje® Compared to the Standard of Care for Non-Healing Diabetic Foot UlcersAugust 21, 2024 | globenewswire.comBSEM Revenues are Growing ExponentiallyAugust 13, 2024 | msn.comBioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 MillionAugust 12, 2024 | globenewswire.comBioStem Technologies is about to announce earnings — here's what Wall Street expectsAugust 11, 2024 | markets.businessinsider.comBiostem Technologies Inc (BSEM)July 24, 2024 | investing.com Get BioStem Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BSEM and its competitors with MarketBeat's FREE daily newsletter. Email Address BSEM Media Mentions By Week BSEM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BSEM News Sentiment▼0.410.74▲Average Medical News Sentiment BSEM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BSEM Articles This Week▼41▲BSEM Articles Average Week Get BioStem Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BSEM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Bicara Therapeutics News Today AbCellera Biologics News Today Xencor News Today Rocket Pharmaceuticals News Today Day One Biopharmaceuticals News Today Praxis Precision Medicines News Today CureVac News Today Immunome News Today LENZ Therapeutics News Today Dianthus Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BSEM) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioStem Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioStem Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
